Cardinal Health 2011 Annual Report Download - page 39

Download and view the complete annual report

Please find page 39 of the 2011 Cardinal Health annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 122

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122

o
perating activities—in a particular location. We may not be able to enter into hedges or obtain insurance t
o
protect us aga
i
nst t
h
ese r
i
s
k
s, an
d
any
h
e
d
ges t
h
at we enter
i
nto or
i
nsurance t
h
at we are a
bl
etoo
b
ta
i
n may
be
expensive and ma
y
not successfull
y
miti
g
ate these risks.
Ris
k
s associate
d
wit
h
t
h
eS
p
in-O
ff
.
CareFusion may not satisfy all of its contractual obligations. We entered into a number of agreements wit
h
C
areFus
i
on t
h
at govern t
h
er
i
g
h
ts an
d
o
bli
gat
i
ons o
f
t
h
e part
i
es
f
o
ll
ow
i
ng t
h
eSp
i
n-O
ff
.We
h
ave certa
i
nr
i
g
h
ts
u
nder those a
g
reements, includin
g
indemnification a
g
ainst certain liabilities allocated to CareFusion. The failur
e
o
f CareFusion to perform its obligations under the agreements could have an adverse effect on our financial
con
di
t
i
on an
d
resu
l
ts o
f
operat
i
ons.
T
he transaction may have unexpected tax consequences. In connection with the Spin-Off, we received a
pr
i
vate
l
etter ru
li
ng
f
rom t
h
e Interna
l
Revenue Serv
i
ce (“IRS”) to t
h
ee
ff
ect t
h
at t
h
e contr
ib
ut
i
on
b
yuso
f
t
h
e
a
ssets of the clinical and medical
p
roducts businesses to CareFusion and the distribution of CareFusion shares to
o
ur shareholders would qualify as a tax-free transaction under Sections 3
55
and 368(a)(1)(D) of the Internal
R
evenue Co
d
e(t
h
e “Co
d
e”). In a
ddi
t
i
on, we rece
i
ve
d
op
i
n
i
ons o
f
tax counse
l
to t
h
ee
ff
ect t
h
at t
h
eSp
i
n-O
ff
would qualif
y
as a transaction that is described in Sections 3
55
(a) and 368(a)(1)(D) of the Code. The IRS private
l
etter ruling and the opinions of counsel rely on certain facts, assumptions, representations and undertakings fro
m
u
san
d
CareFus
i
on regar
di
ng t
h
e past an
df
uture con
d
uct o
f
t
h
e compan
i
es’ respect
i
ve
b
us
i
nesses an
d
ot
h
e
r
matters. If an
y
of these facts, assumptions, representations or undertakin
g
s is incorrect or not otherwise satisfied,
we and our shareholders may not be able to rely on the IRS ruling or the opinions of tax counsel. Similarly, th
e
I
RS cou
ld d
eterm
i
ne on au
di
tt
h
at t
h
eSp
i
n-O
ff i
s taxa
bl
e
if i
t
d
eterm
i
nes t
h
at any o
f
t
h
e
f
acts, assumpt
i
ons,
representations or undertakin
g
s are not correct or have been violated or if the IRS disa
g
rees with the conclusion
s
in the opinions of counsel that are not covered by the private letter ruling or for other reasons, including as a
resu
l
to
f
certa
i
ns
i
gn
ifi
cant c
h
anges
i
n stoc
k
owners
hi
po
f
e
i
t
h
er Car
di
na
l
Hea
l
t
h
or CareFus
i
on. I
f
t
h
eSp
i
n-O
ff
is determined to be taxable for United States federal income tax
p
ur
p
oses, we and our shareholders that ar
e
subject to United States federal income tax could incur significant tax liabilities
.
I
t
e
m 1B: Unreso
l
ve
d
Sta
ff
Comments
Not app
li
ca
bl
e
.
I
tem
2
:
P
ropert
i
es
I
n the United States, the Pharmaceutical se
g
ment operates 24 pharmaceutical distribution facilities and one
national logistics center; four specialty distribution facilities; and 168 nuclear pharmacy laboratory,
manufacturing and distribution facilities. The Medical segment operates 50 medical-surgical distribution,
a
ssembl
y
, manufacturin
g
, and research operation facilities. Our United States operatin
g
facilities are located i
n
4
5
states and in Puerto Rico
.
O
ur Pharmaceutical se
g
ment also operates 13 pharmaceutical distribution facilities in China, and our
Medical segment operates 17 facilities in Canada, the Dominican Republic, Malaysia, Malta, Mexico, and
Th
a
il
an
d
t
h
at engage
i
n manu
f
actur
i
ng,
di
str
ib
ut
i
on or researc
h
.
We own 67 operating facilities and lease 210 operating facilities. Our principal executive offices are
h
ea
d
quartere
di
n an owne
df
our-story
b
u
ildi
ng
l
ocate
d
at 7000 Car
di
na
l
P
l
ace
i
nDu
bli
n, O
hi
o.
We consider our operating properties to be in satisfactory condition and adequate to meet our present needs
.
H
owever, we regu
l
ar
l
y eva
l
uate operat
i
ng propert
i
es an
d
may ma
k
e
f
urt
h
er a
ddi
t
i
ons an
di
mprovements o
r
consolidate locations as we seek o
pp
ortunities to ex
p
and our business
.
13